Strategic Equity Allocation Fund (continued) | Strategic Equity Allocation Fund (continued) |
| Shares or | | | | Shares or | | |
| Principal | | | | Principal | | |
| Amount | | Value | | Amount | | Value |
COMMON STOCKS (continued) | | | | | COMMON STOCKS (continued) | | | | |
Biotechnology (continued) | | | | | Biotechnology (continued) | | | | |
Assembly Biosciences, Inc. (A) | 5,310 | $ | 26,975 | Flexion Therapeutics, Inc. (A)(C) | 6,508 | $ | 71,718 |
Atara Biotherapeutics, Inc. (A) | 11,233 | | 188,490 | Forma Therapeutics | | | | |
Athenex, Inc. (A) | 10,624 | | 128,550 | Holdings, Inc. (A)(C) | 2,487 | | 96,023 |
Athersys, Inc. (A)(C) | 26,127 | | 53,299 | Fortress Biotech, Inc. (A) | 12,063 | | 44,874 |
Atreca, Inc., Class A (A) | 4,473 | | 77,607 | Frequency Therapeutics, Inc. (A)(C) | 3,714 | | 182,766 |
AVEO Pharmaceuticals, Inc. (A) | 3,891 | | 32,140 | G1 Therapeutics, Inc. (A) | 5,091 | | 112,511 |
Avid Bioservices, Inc. (A) | 8,391 | | 172,687 | Galapagos NV (A) | 4,979 | | 411,123 |
Avidity Biosciences, Inc. (A) | 2,750 | | 66,358 | Generation Bio Company (A)(C) | 1,983 | | 69,246 |
Avrobio, Inc. (A) | 4,766 | | 52,426 | Genmab A/S (A) | 6,919 | | 2,320,533 |
Beam Therapeutics, Inc. (A)(C) | 5,848 | | 521,232 | Genprex, Inc. (A) | 5,769 | | 29,768 |
BeiGene, Ltd., ADR (A)(C) | 4,700 | | 1,504,000 | Geron Corp. (A)(C) | 43,056 | | 77,070 |
Beyondspring, Inc. (A) | 2,804 | | 36,396 | Gilead Sciences, Inc. | 127,829 | | 7,848,701 |
BioCryst Pharmaceuticals, Inc. (A)(C) | 26,065 | | 280,981 | Gossamer Bio, Inc. (A) | 8,599 | | 80,831 |
Biogen, Inc. (A) | 15,692 | | 4,282,033 | Grifols SA | 33,721 | | 844,846 |
Biohaven Pharmaceutical Holding | | | | | Gritstone Oncology, Inc. (A) | 4,767 | | 64,688 |
Company, Ltd. (A) | 7,087 | | 602,253 | Halozyme Therapeutics, Inc. (A) | 48,680 | | 2,202,770 |
Bioxcel Therapeutics, Inc. (A)(C) | 1,842 | | 98,750 | Harpoon Therapeutics, Inc. (A) | 1,896 | | 36,574 |
Black Diamond Therapeutics, Inc. (A) | 2,715 | | 76,020 | Heron Therapeutics, Inc. (A) | 13,088 | | 236,631 |
Blueprint Medicines Corp. (A) | 8,129 | | 798,430 | Homology Medicines, Inc. (A) | 5,684 | | 61,046 |
BrainStorm Cell | | | | | Hookipa Pharma, Inc. (A) | 2,574 | | 30,476 |
Therapeutics, Inc. (A)(C) | 4,868 | | 19,764 | iBio, Inc. (A)(C) | 26,364 | | 46,401 |
Bridgebio Pharma, Inc. (A)(C) | 13,647 | | 964,570 | Ideaya Biosciences, Inc. (A) | 2,684 | | 51,184 |
C4 Therapeutics, Inc. (A)(C) | 1,677 | | 71,977 | IGM Biosciences, Inc. (A)(C) | 1,027 | | 89,791 |
Cabaletta Bio, Inc. (A) | 2,505 | | 27,229 | ImmunoGen, Inc. (A) | 27,338 | | 239,208 |
Calithera Biosciences, Inc. (A) | 11,882 | | 34,695 | Immunovant, Inc. (A) | 5,490 | | 86,632 |
CareDx, Inc. (A) | 7,015 | | 554,746 | Incyte Corp. (A) | 18,982 | | 1,493,124 |
CASI Pharmaceuticals, Inc. (A) | 11,659 | | 28,681 | Inhibrx, Inc. (A)(C) | 1,343 | | 34,139 |
Catalyst Pharmaceuticals, Inc. (A) | 15,343 | | 59,684 | Innovent Biologics, Inc. (A)(B) | 102,000 | | 1,049,666 |
Celltrion, Inc. (A) | 9,427 | | 2,491,715 | Inovio Pharmaceuticals, Inc. (A)(C) | 23,277 | | 258,375 |
CEL-SCI Corp. (A)(C) | 4,928 | | 87,472 | Inozyme Pharma, Inc. (A)(C) | 1,430 | | 28,600 |
Checkpoint Therapeutics, Inc. (A) | 9,674 | | 31,054 | Insmed, Inc. (A) | 14,884 | | 532,401 |
ChemoCentryx, Inc. (A) | 7,281 | | 493,943 | Intellia Therapeutics, Inc. (A) | 7,349 | | 444,321 |
Chimerix, Inc. (A) | 7,080 | | 69,455 | Intercept Pharmaceuticals, Inc. (A) | 3,888 | | 84,214 |
Chinook Therapeutics, Inc. (A) | 2,372 | | 39,233 | Invitae Corp. (A)(C) | 16,917 | | 678,879 |
Clovis Oncology, Inc. (A)(C) | 12,278 | | 73,545 | Ironwood Pharmaceuticals, Inc. (A) | 23,493 | | 216,840 |
Coherus Biosciences, Inc. (A) | 8,747 | | 142,051 | iTeos Therapeutics, Inc. (A) | 1,616 | | 67,193 |
Concert Pharmaceuticals, Inc. (A) | 5,629 | | 37,658 | IVERIC bio, Inc. (A) | 11,703 | | 71,856 |
Constellation Pharmaceuticals, Inc. (A) | 4,555 | | 114,786 | Jounce Therapeutics, Inc. (A) | 2,910 | | 31,952 |
Corbus Pharmaceuticals | | | | | Kadmon Holdings, Inc. (A) | 25,628 | | 117,633 |
Holdings, Inc. (A)(C) | 13,709 | | 29,886 | KalVista Pharmaceuticals, Inc. (A) | 2,240 | | 73,629 |
Cortexyme, Inc. (A)(C) | 2,295 | | 78,191 | Karuna Therapeutics, Inc. (A) | 2,334 | | 291,657 |
Crinetics Pharmaceuticals, Inc. (A) | 4,263 | | 65,181 | Karyopharm Therapeutics, Inc. (A) | 10,518 | | 145,359 |
CSL, Ltd. | 51,622 | | 10,520,499 | Keros Therapeutics, Inc. (A) | 1,932 | | 126,488 |
Cue Biopharma, Inc. (A) | 4,894 | | 66,607 | Kezar Life Sciences, Inc. (A) | 6,247 | | 34,234 |
Cytokinetics, Inc. (A) | 9,856 | | 184,603 | Kindred Biosciences, Inc. (A) | 6,956 | | 31,372 |
CytomX Therapeutics, Inc. (A) | 7,639 | | 59,966 | Kiniksa Pharmaceuticals, Ltd., | | | | |
Deciphera Pharmaceuticals, Inc. (A) | 5,658 | | 247,707 | Class A (A) | 4,033 | | 82,959 |
Denali Therapeutics, Inc. (A) | 9,219 | | 661,924 | Kodiak Sciences, Inc. (A) | 4,722 | | 609,185 |
DermTech, Inc. (A) | 1,272 | | 84,881 | Kronos Bio, Inc. (A)(C) | 2,283 | | 66,367 |
Dicerna Pharmaceuticals, Inc. (A) | 9,778 | | 263,810 | Krystal Biotech, Inc. (A) | 2,029 | | 160,068 |
Dynavax Technologies Corp. (A) | 15,789 | | 138,154 | Kura Oncology, Inc. (A) | 9,054 | | 253,512 |
Dyne Therapeutics, Inc. (A) | 2,384 | | 44,032 | Kymera Therapeutics, Inc. (A)(C) | 1,490 | | 71,490 |
Eagle Pharmaceuticals, Inc. (A) | 1,512 | | 67,284 | Lexicon Pharmaceuticals, Inc. (A) | 6,540 | | 47,023 |
Editas Medicine, Inc. (A) | 9,216 | | 404,214 | Ligand Pharmaceuticals, Inc. (A)(C) | 5,801 | | 859,824 |
Eiger BioPharmaceuticals, Inc. (A) | 4,574 | | 46,518 | MacroGenics, Inc. (A) | 8,124 | | 203,181 |
Emergent BioSolutions, Inc. (A) | 16,958 | | 1,627,968 | Madrigal Pharmaceuticals, Inc. (A) | 1,300 | | 157,547 |
Enanta Pharmaceuticals, Inc. (A) | 2,862 | | 141,154 | Magenta Therapeutics, Inc. (A) | 3,772 | | 39,644 |
Epizyme, Inc. (A) | 13,391 | | 128,420 | MannKind Corp. (A) | 33,165 | | 189,372 |
Esperion Therapeutics, Inc. (A)(C) | 3,848 | | 105,397 | MediciNova, Inc. (A)(C) | 6,669 | | 37,213 |
Evelo Biosciences, Inc. (A)(C) | 3,189 | | 38,810 | MEI Pharma, Inc. (A) | 16,415 | | 61,556 |
Exelixis, Inc. (A) | 71,246 | | 1,543,188 | MeiraGTx Holdings PLC (A) | 3,763 | | 55,843 |
Fate Therapeutics, Inc. (A) | 11,027 | | 989,342 | Mersana Therapeutics, Inc. (A) | 7,874 | | 143,149 |
Fennec Pharmaceuticals, Inc. (A) | 4,095 | | 29,975 | Mirati Therapeutics, Inc. (A) | 6,268 | | 1,259,367 |
FibroGen, Inc. (A) | 12,390 | | 619,872 | Molecular Templates, Inc. (A) | 4,372 | | 47,655 |
Five Prime Therapeutics, Inc. (A) | 4,504 | | 100,124 | Morphic Holding, Inc. (A) | 2,083 | | 75,321 |